Skip to main content
Back to news
Regulation

Injective CEO Eric Chen Says US INJ ETFs Could Launch Before 2027

(5 hours ago) · 1 source · Summarized by CryptoBipto

Injective CEO Eric Chen has stated his expectation that exchange-traded funds (ETFs) based on the INJ token will launch in the United States sooner than 2027. The timeline for such a product remains uncertain, as regulatory approval from the SEC would be required.

WHY IT MATTERS

An ETF, or exchange-traded fund, is a financial product that lets people invest in an asset through traditional stock exchanges without having to buy or hold the asset directly. Think of it like buying a share in a basket that holds the asset for you. If an INJ ETF were approved, it would make it easier for everyday investors and institutions to gain exposure to the INJ token through their regular brokerage accounts, similar to how Bitcoin ETFs made it simpler to invest in Bitcoin. However, a CEO's expectation is not the same as a regulatory decision, and there is no guarantee such a product will be approved.

Eric Chen, the CEO of Injective, a blockchain protocol focused on decentralized finance, has publicly expressed his belief that ETFs tied to the INJ token could receive approval and launch in the US before 2027.

Read the full analysis with a CryptoBipto membership

Members can read the full analysis of every story, not just the headline.

Get started

SOURCES

  • theblock.co

RELATED

INJETFsSEC RegulationAltcoin ETFsInjective